Mortality associated with healthcareassociated Staphylococcus aureus bacteraemia in Aotearoa New Zealand
New Zealand Medical Journal · 12.06.2026 · 139 (1636) · 52-59
DOI: 10.26635/6965.7321 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Zealand Medical Journal, online erschienen am 12.06.2026. Verfasst von Sally A Roberts und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland; National Clinical Lead, Infection Prevention and Control Programme…. Hauptthemen laut MEDLINE: Staphylococcal Infections, Bacteremia, Cross Infection, Staphylococcus aureus.
Abstract (Originalsprache)
aim: Our aim was to determine the 30- and 90-day all-cause mortality of healthcare-associated Staphylococcus aureus bacteraemia (HA-SAB) and determine mortality risk factors. method: We collected HA-SAB events from 1 July 2022 to 30 June 2024. Patient age, sex, ethnicity and source of HA-SAB were submitted via a secure portal. Patients’ National Health Index numbers were matched to the National Minimum Dataset, and 30- and 90-day allcause mortality was determined. The mortality rate was calculated as a percentage of all HA-SAB events and by age, sex, ethnicity and source. results: There were 961 HA-SAB events: a rate of 0.15 cases per 1,000 inpatient bed days. Thirty- and 90-day all-cause mortality were 13.8% and 20.7%, respectively. There was no difference in mortality by sex or ethnicity. Mortality increased with age and increased significantly for ≥75 years of age. Invasive medical devices were the source of 70% of HA-SAB events, organs were the source of 12% of HA-SAB events, and surgical site infections were the source of 8% of HA-SAB events. conclusion: The 30- and 90-day all-cause mortality associated with HA-SAB is high. The most common sources are vascular access devices. The use of a “care bundle” incorporating proven interventions, applied using a quality improvement framework, should reduce patient harm from these events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Microbiologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland; National Clinical Lead, Infection Prevention and Control Programme, Health Quality & Safety Commission Te Tāhū Hauora, Auckland, New Zea…
- Data Analyst, Health Quality & Safety Commission Te Tāhū Hauora, Auckland, New Zealand.
- Specialist, Infection Prevention and Control Programme, Health Quality & Safety Commission Te Tāhū Hauora, Wellington, New Zealand.
- Clinical Microbiologist, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland; Clinical Lead, Infection Prevention and Control Programme, Health Quality & Safety Commission Te Tāhū Hauora, Auckland, New Zealand.
- Senior Manager, Health Quality & Safety Commission Te Tāhū Hauora, Auckland, New Zealand.
Zitieren
APA
Roberts, S. A., Waddell, D., Atkins, S., Morris, A. J., & Grae, N. (2026). Mortality associated with healthcareassociated Staphylococcus aureus bacteraemia in Aotearoa New Zealand. New Zealand Medical Journal, 139(1636), 52-59. https://doi.org/10.26635/6965.7321
Vancouver
Roberts SA, Waddell D, Atkins S, Morris AJ, Grae N. Mortality associated with healthcareassociated Staphylococcus aureus bacteraemia in Aotearoa New Zealand. New Zealand Medical Journal. 2026;139(1636):52-59. doi:10.26635/6965.7321
BibTeX
@article{Roberts2026,
author = {Roberts, Sally A and Waddell, David and Atkins, Sue and Morris, Arthur J and Grae, Nikki},
title = {Mortality associated with healthcareassociated Staphylococcus aureus bacteraemia in Aotearoa New Zealand},
journal = {New Zealand Medical Journal},
year = {2026},
volume = {139},
number = {1636},
pages = {52--59},
doi = {10.26635/6965.7321}
}
EUVIMED